Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -33.33% | 0.00% | -50.00% |
Feb. 29 | Braxia Scientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Braxia Scientific Corp. Announces Board Changes | CI |
Sales 2022 | 1.49 2.03 | Sales 2023 | 1.88 2.58 | Capitalization | 6.59M 9.01M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.4M | Net income 2023 | -13M -17.77M | EV / Sales 2022 | 2,322,657 x |
Net cash position 2022 | 8.46M 11.57M | Net cash position 2023 | 1.26M 1.72M | EV / Sales 2023 | 2,832,851 x |
P/E ratio 2022 |
-0.87
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.58% |
1 day | -33.33% | ||
1 month | -50.00% | ||
6 months | -50.00% | ||
Current year | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Roger McIntyre
CEO | Chief Executive Officer | - | 20-05-10 |
Peter Rizakos
DFI | Director of Finance/CFO | - | 21-01-07 |
Jason Wolkove
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jerry Habuda
BRD | Director/Board Member | 67 | 19-08-18 |
Roger McIntyre
CEO | Chief Executive Officer | - | 20-05-10 |
Olga Cwiek
BRD | Director/Board Member | - | 21-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.005 | -33.33% | 159,219 |
24-05-09 | 0.0075 | -25.00% | 12,331 |
24-05-08 | 0.01 | +100.00% | 13,300 |
24-05-07 | 0.005 | -33.33% | 3,400 |
Delayed Quote Canadian Securities Exchange, May 10, 2024 at 01:20 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.00% | 1.04M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- BRAX Stock